COVID-19 during pregnancy: a prospective observational cohort
Suspended
- Conditions
- COVID-19 during pregnancy
- Registration Number
- NL-OMON22532
- Lead Sponsor
- Máxima MC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Pregnant women who tested positive on SARS-CoV-2, regardless of the presence or absence of any clinical symptoms
Exclusion Criteria
Women <18 years old
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -To describe the clinical presentation (symptoms) of pregnant women who tested positive on SARS-CoV-2<br>-To describe the clinical course of COVID-19 infection during pregnancy
- Secondary Outcome Measures
Name Time Method -To describe riskfactors associated with a severe clinical course of COVID-19 during pregnancy (severe clinical course is defined as: admission to intensive care unit of in case of mortality)<br>-To describe the number of transmission of SARS-CoV-2 from mother to neonate and when possible determine factors associated with an increased risk of transmission (e.g. breastfeeding)<br>-To evaluate/describe any treatments given during admission<br>-To describe whether COVID-19 might be associated with preterm birth, intrauterine growth restriction of neonatal congenital disorders